목차

intestinal perforation

Introduction

History of the Procedure

Lau and Leow have indicated that perforated peptic ulcer was clinically recognized by 1799, but the first successful surgical management of gastric ulcer was by Ludwig Heusner in Germany in 1892. In 1894, Henry Percy Dean from London was the first surgeon to report successful repair of a perforated duodenal ulcer.1

Partial gastrectomy, although performed for perforated gastric ulcer as early as 1892, did not become a popular treatment until the 1940s. This was carried out as a result of the perceived high recurrence rate of ulcer symptoms after simple repair. The physiologic effects of truncal vagotomy on acid secretion had been known since the early 19th century, and this approach was introduced to the treatment of chronic duodenal ulcer in the 1940s. The next development in the management of peptic ulcer disease was the introduction of high selective vagotomy in the late 1960s. However, neither of these approaches proved to be useful, and several postoperative complications, including high rates of ulcer recurrence, have limited their use. Currently, in patients with gastric perforation, simple closure of perforated ulcers is more commonly performed than is gastric resection.2

During World War I, the mortality rate following isolated injuries of the small intestine and colon was approximately 66% and 59%, respectively. The possible reasons for the high mortality and morbidity rates at that time may have been related to the following factors:

During the early years of World War II, Ogilvie, a leading surgeon in the British Army, recommended colostomy for management of all colonic injuries. This notion was supported by a publication from the office of the Surgeon General of the United States. However, the data presented in Ogilvie's series were not convincing. He reported a mortality rate of 53% for colonic injuries treated with colostomy, a rate similar to that observed during World War I.

According to Ogilvie, colostomy apparently failed to improve the mortality rate in World War II because primary repairs were used to treat less-severe injuries during World War I. Many patients in World War I were treated expectantly and were not included in the mortality data. On the other hand, Ogilvie's data included all patients with bowel injuries. These apparent differences in the methodology used convinced surgeons to continue using colostomies in such injuries after World War II.

Several reports clearly indicated that surgeons used colostomy during the Korean and Vietnam wars, particularly in the management of left colonic injuries. However, in civilian injuries, it has been reported that primary repair can be successfully used. By the end of 1980s, primary repair was considered to the management strategy of choice, and it has replaced the use of colostomies in the treatment of civilian patients in most hospitals in the United States, the United Kingdom, Europe, and Australia. At present, primary repairs are widely used for such bowel injuries.

Problem

Upper bowel perforation can be described as either free or contained. Free perforation occurs when bowel contents spill freely into the abdominal cavity, causing diffuse peritonitis (eg, duodenal or gastric perforation). Contained perforation occurs when a full-thickness hole is created by an ulcer, but free spillage is prevented because contiguous organs wall off the area (as occurs, for example, when a duodenal ulcer penetrates into the pancreas).

Lower bowel perforation (eg, in patients with acute diverticulitis or acute appendicitis) results in free intraperitoneal contamination.

Frequency

In children, small bowel injuries following blunt abdominal trauma are infrequent, with an incidence of 1-7%. Evidence shows, however, that the incidence of these injuries is increasing.

In adults, perforations of peptic ulcer disease were a common cause of morbidity and mortality with acute abdomen until the latter half of the 20th century. The rate has fallen in parallel with the general decline in the prevalence of peptic ulcer disease. Duodenal ulcer perforations are 2-3 times more common than are gastric ulcer perforations. About a third of gastric perforations are due to gastric carcinoma.

Approximately 10-15% of patients with acute diverticulitis develop free perforation. Although most episodes of perforated diverticulum are confined to the peridiverticular region or pelvis, patients occasionally present with signs of generalized peritonitis. The overall mortality rate is relatively high (~20-40%), largely because of complications, such as septic shock and multiorgan failure.

In elderly patients, acute appendicitis has a mortality rate of 35% and a morbidity rate of 50%. A major contributing factor to morbidity and mortality in these patients is the presence of 1 or more severe medical conditions coexisting with, but predating, the appendicitis.

Endoscopy-associated bowel injuries are not a common cause of perforation. For example, perforations related to endoscopic retrograde cholangiopancreatography (ERCP) occur in about 1% of patients.3

Etiology

Pathophysiology

Normally, the stomach is relatively free of bacteria and other microorganisms because of its high intraluminal acidity. Most persons who experience abdominal trauma have normal gastric functions and are not at risk of bacterial contamination following gastric perforation. However, those who have a preexisting gastric problem are at risk of peritoneal contamination with gastric perforation. Leakage of acidic gastric juice into the peritoneal cavity often results in profound chemical peritonitis. If the leakage is not closed and food particles reach the peritoneal cavity, chemical peritonitis is succeeded by gradual development of bacterial peritonitis. Patients may be free of symptoms for several hours between the initial chemical peritonitis and the later occurrence of bacterial peritonitis.

The microbiology of the small bowel changes from its proximal to its distal part. Few bacteria populate the proximal part of the small bowel, whereas the distal part of the small bowel (the jejunum and ileum) contains aerobic organisms (eg, Escherichia coli) and a higher percentage of anaerobic organisms (eg, Bacteroides fragilis). Thus, the likelihood of intra-abdominal or wound infection is increased with perforation of the distal bowel.

The presence of bacteria in the peritoneal cavity stimulates an influx of acute inflammatory cells. The omentum and viscera tend to localize the site of inflammation, producing a phlegmon. (This usually occurs in perforation of the large bowel.) The resulting hypoxia in the area facilitates growth of anaerobes and produces impairment of bactericidal activity of granulocytes, which leads to increased phagocytic activity of granulocytes, degradation of cells, hypertonicity of fluid forming the abscess, osmotic effects, shift of more fluids into the abscess area, and enlargement of the abdominal abscess. If untreated, bacteremia, generalized sepsis, multiorgan failure, and shock may occur. Presentation

History

A careful medical history often suggests the source of the problem, which is subsequently confirmed by clinical examination and radiologic study findings. Possible etiologies include the following:

Physical

Differential diagnosis

Relevant Anatomy

The peritoneal cavity is lined with a single layer of mesothelial cells, connective tissue (including collagen), elastic tissues, macrophages, and fat cells. The parietal peritoneum covers the abdominal cavity (ie, abdominal wall, diaphragm, pelvis); the visceral peritoneum covers all of the intra-abdominal viscera, forming a cavity that is completely enclosed except at the open ends of the fallopian tubes.

The peritoneal cavity is divided by the transverse mesocolon. The greater omentum extends from the transverse mesocolon and from the lower pole of the stomach to line the lower peritoneal cavity. Abdominal organs, such as the pancreas, duodenum, and ascending and descending colon, are located in the anterior retroperitoneal space; the kidneys, ureters, and adrenal glands are found in the posterior retroperitoneal space. Other abdominal organs, the liver, stomach, gallbladder, spleen, jejunum, ileum, transverse colon, sigmoid colon, cecum, and appendix are found within the peritoneal cavity.

A small amount of fluid sufficient to allow movement of organs is usually present in the peritoneal space. This fluid is normally serous (protein content of <30 g/L, <300 WBCs/µL). In the presence of infection, the amount of this fluid increases, its protein content climbs to more than 30 g/L, and the white blood cell (WBC) count increases to more than 500 WBCs/µL; in other words, the fluid becomes an exudate. Contraindications

Workup

Laboratory Studies

Imaging Studies

Other Tests

Diagnostic Procedures

Treatment

Medical Therapy

The mainstay of treatment for intestinal perforation is surgery.14 Emergency medical care includes the following steps:

However, if symptoms and signs of generalized peritonitis are absent, a nonoperative policy may be used with antibiotic therapy directed against gram-negative and anaerobic bacteria.15, 16

DRUG CATEGORY: Antibiotics – Have proven effective in decreasing the rate of postoperative wound infection and in improving outcome in patients with intraperitoneal infection and septicemia.

Drug Name - Metronidazole (Flagyl) - Typically used in combination with an aminoglycoside to provide broad gram-negative and anaerobic coverage. Reduced to a product that interacts with deoxyribonucleic acid (DNA) to cause a loss of helical DNA structure and strand breakage, resulting in inhibition of protein synthesis and cell death in susceptible organisms. Adult Dose - 7.5 mg/kg IV before surgery. Pediatric Dose - 15-30 mg/kg/d IV divided bid/tid for 7 d. Contraindications - Documented hypersensitivity; first trimester of pregnancy Interactions - Alcohol may cause disulfiramlike reactions; may increase toxicity of anticoagulants, lithium, and phenytoin; phenobarbital and rifampin may increase metabolism Pregnancy - B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals Precautions - Adjust dose in hepatic disorders; monitor for seizures and development of peripheral neuropathy

Drug Name - Gentamicin (Garamycin, Genoptic, Gentacidin) - Aminoglycoside antibiotic for gram-negative coverage. Used in combination with both an agent against gram-positive organisms and one that covers anaerobes. Not DOC. Consider if penicillins or other less-toxic drugs are contraindicated, when clinically indicated, and in mixed infections caused by susceptible staphylococci and gram-negative organisms. Dosing regimens are numerous; adjust dose based on CrCl and changes in volume of distribution. May be given IV/IM. Adult Dose - Loading dose before surgery: 2 mg/kg IV; thereafter, 3-5 mg/kg/d divided tid/qid. Pediatric Dose - Infants: 7.5 mg/kg/d IV divided tid. Children: 6-7.5 mg/kg/d IV divided tid. Contraindications - Documented hypersensitivity; non–dialysis-dependent renal insufficiency Interactions - Coadministration with cephalosporins, penicillins, and amphotericin B may increase nephrotoxicity; coadministration with loop diuretics may increase ototoxicity of aminoglycosides; aminoglycosides enhance effects of neuromuscular blocking agents, and thus, prolonged respiratory depression may occur (monitor regularly) Pregnancy - C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus Precautions - Parenteral aminoglycosides associated with significant nephrotoxicity or ototoxicity; ototoxicity is directly proportional to amount of drug given and duration of treatment; tinnitus and vertigo are indications of vestibular injury and impending irreversible bilateral deafness; renal damage usually reversible; adjust dose in renal impairment; narrow therapeutic index (not intended for long-term therapy); caution in renal failure (not on dialysis), myasthenia gravis, hypocalcemia, and conditions that depress neuromuscular transmission

Drug Name - Cefotetan (Cefotan) - Second-generation cephalosporin that inhibits bacterial cell wall synthesis by binding to 1 or more of the penicillin-binding proteins; inhibits final transpeptidation step of peptidoglycan synthesis, resulting in cell wall death. Adult Dose - 2 g IV once before surgery. Pediatric Dose - <3 months: Not established. >3 months: 30-40 mg/kg IV once before surgery. Contraindications - Documented hypersensitivity Interactions - Consumption of alcohol within 72 h of cefotetan may produce disulfiramlike reactions; may increase hypoprothrombinemic effects of anticoagulants; coadministration with potent diuretics (eg, loop diuretics) or aminoglycosides may increase nephrotoxicity; test interactions: positive Coombs (direct), false-positive urine glucose (Clinitest), false increase in serum or urine creatinine Pregnancy - B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals Precautions - Prolonged use may result in superinfection; high doses in children have been associated with increased incidence of eosinophilia and elevated serum AST; reduce dose by 1/2 if CrCl <10-30 mL/min and by 1/4 if <10 mL/min (high doses may cause CNS toxicity); caution in patients with history of colitis or penicillin allergy

Drug Name - Cefoxitin (Mefoxin) – Second-generation cephalosporin that inhibits bacterial cell wall synthesis by binding to 1 or more of the penicillin-binding proteins; inhibits final transpeptidation step of peptidoglycan synthesis, resulting in cell wall death. Adult Dose - 2 g IV once before surgery, followed by 4 doses of 2 g IV q4-6h. Pediatric Dose - <3 months: Not established. >3 months: 30-40 mg/kg IV before surgery; followed by 3 doses of 2 g IV q4-6h for 24 h. Contraindications - Documented hypersensitivity Interactions - Coadministration with aminoglycosides or furosemide may increase nephrotoxicity, so close monitoring of renal function needed; test interactions: positive Coombs (direct), false-positive urine glucose (Clinitest), false increase in serum or urine creatinine Pregnancy - B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals Precautions - Prolonged use may result in superinfection; high doses in children have been associated with increased incidence of eosinophilia and elevated serum AST; caution and modify dose in renal impairment; caution in patients with history of colitis or penicillin allergy

Drug Name - Cefoperazone sodium (Cefobid) - Third-generation cephalosporin that inhibits bacterial cell wall synthesis by binding to 1 or more of the penicillin-binding proteins; inhibits final transpeptidation step of peptidoglycan synthesis, resulting in cell wall death. Adult Dose - 2-4 g/d IV divided q12h. Pediatric Dose - 100-150 mg/kg/d IV divided q8-12h; not to exceed 12 g/d. Contraindications - Documented hypersensitivity Interactions - Coadministration with aminoglycosides or furosemide may increase nephrotoxicity (monitor closely); test interactions: positive Coombs (direct), false-positive urine glucose (Clinitest) Pregnancy - B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals Precautions - Prolonged use may result in superinfection; caution and modify dose in severe renal impairment or hepatic dysfunction; caution in patients with history of colitis or penicillin allergy; may reduce vitamin K–producing intestinal bacteria and interfere with hemostasis

Related eMedicine topic: Antibiotics: A Review of ED Use Surgical Therapy

The goals of surgical therapy are as follows:

Related eMedicine topic: Peptic Ulcer: Surgical Perspective Peritonitis and Abdominal Sepsis Preoperative Details

Intraoperative Details

Operative management depends on the cause of perforation. Perform urgent surgery either on patients not responding to resuscitation or following stabilization and maintenance of adequate urine output. All necrotic material and contaminated fluid should be removed and accompanied by lavage with antibiotics (tetracycline 1 mg/mL). Decompress distended bowel via a nasogastric tube.

Laparoscopic or laparoscopic-assisted (minilaparotomy) surgery is also being increasingly used with outcomes comparable with conventional laparotomy. Experience and the advancement in accessories have enabled endoscopic repair of a significant number of intestinal perforations, such as iatrogenic perforation. Management of such cases needs to be individualized to the patient. Postoperative Details

Follow-up

For patients treated with a nonsurgical approach, follow-up care consists of the following:

Complications

Outcome and Prognosis

Outcome is improved with early diagnosis and treatment. The following factors increase the risk of death:

Future and Controversies

Medicolegal pitfalls include the following: